Movement Alert｜Johnson & Johnson falls 3.31% in Pre-Market Trading, post-earnings drop deepens as orthopaedics separation draws focus

Market Focus

4 hours ago

On October 13, Johnson & Johnson fell 3.31% in Pre-Market Trading, trading at $255.9 per share, with turnover of $7.1785 million.

The move followed its latest quarterly report and management commentary on portfolio restructuring. Third-quarter sales were $25.4 billion, broadly in line with expectations, while adjusted EPS of $2.59 beat consensus estimates. The company also raised full-year sales guidance to $101.0 billion-$101.4 billion and adjusted EPS guidance to $11.05-$11.15.

Despite the earnings beat and higher outlook, management said it prefers to separate the hips and knees orthopaedics business rather than sell it, with the CFO indicating a target completion around mid-2027. The sharper pre-market decline suggests investors are weighing the implications of the MedTech portfolio reshaping and its effect on future growth mix and valuation.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1193024757"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1193024757\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1193024757?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-10-13 19:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1193024757","market":"us","top_or_hot":-1,"title":"Movement Alert｜Johnson & Johnson falls 3.31% in Pre-Market Trading, post-earnings drop deepens as orthopaedics separation draws focus","media":"Market Focus","content":"<p><p>On October 13, Johnson & Johnson fell 3.31% in Pre-Market Trading, trading at $255.9 per share, with turnover of $7.1785 million.</p><p>The move followed its latest quarterly report and management commentary on portfolio restructuring. Third-quarter sales were $25.4 billion, broadly in line with expectations, while adjusted EPS of $2.59 beat consensus estimates. The company also raised full-year sales guidance to $101.0 billion-$101.4 billion and adjusted EPS guidance to $11.05-$11.15.</p><p>Despite the earnings beat and higher outlook, management said it prefers to separate the hips and knees orthopaedics business rather than sell it, with the CFO indicating a target completion around mid-2027. The sharper pre-market decline suggests investors are weighing the implications of the MedTech portfolio reshaping and its effect on future growth mix and valuation.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Johnson & Johnson falls 3.31% in Pre-Market Trading, post-earnings drop deepens as orthopaedics separation draws focus</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Johnson & Johnson falls 3.31% in Pre-Market Trading, post-earnings drop deepens as orthopaedics separation draws focus\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-10-13 19:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On October 13, Johnson & Johnson fell 3.31% in Pre-Market Trading, trading at $255.9 per share, with turnover of $7.1785 million.</p><p>The move followed its latest quarterly report and management commentary on portfolio restructuring. Third-quarter sales were $25.4 billion, broadly in line with expectations, while adjusted EPS of $2.59 beat consensus estimates. The company also raised full-year sales guidance to $101.0 billion-$101.4 billion and adjusted EPS guidance to $11.05-$11.15.</p><p>Despite the earnings beat and higher outlook, management said it prefers to separate the hips and knees orthopaedics business rather than sell it, with the CFO indicating a target completion around mid-2027. The sharper pre-market decline suggests investors are weighing the implications of the MedTech portfolio reshaping and its effect on future growth mix and valuation.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"JNJ","symbol_name":"强生","start_time":0,"source_url":"","article_id":"1193024757","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1193024757","pubTimestamp":1791889383,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On October 13, Johnson & Johnson fell 3.31% in Pre-Market Trading, trading at $255.9 per share, with turnover of $7.1785 million.The move followed its latest quarterly report and management...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"JNJ":"强生"},"translate_title":"走势警报|强生公司盘前交易下跌 3.31%，骨科分离引发关注，财报后跌幅加深","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"JNJ":1},"content_text":"On October 13, Johnson & Johnson fell 3.31% in Pre-Market Trading, trading at $255.9 per share, with turnover of $7.1785 million.The move followed its latest quarterly report and management commentary on portfolio restructuring. Third-quarter sales were $25.4 billion, broadly in line with expectations, while adjusted EPS of $2.59 beat consensus estimates. The company also raised full-year sales guidance to $101.0 billion-$101.4 billion and adjusted EPS guidance to $11.05-$11.15.Despite the earnings beat and higher outlook, management said it prefers to separate the hips and knees orthopaedics business rather than sell it, with the CFO indicating a target completion around mid-2027. The sharper pre-market decline suggests investors are weighing the implications of the MedTech portfolio reshaping and its effect on future growth mix and valuation.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}